Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by Yellowknifer69on Aug 21, 2020 9:30am
425 Views
Post# 31437627

AGM

AGMHello and good morning ATE Longs:

First off, hope that you all have had time to de-escalate and enjoy some summer!

Well the AGM was more of a nothing burger to me but I did note that the option to consolidate shares was approved.  I n my opinion, I would suspect that any share consolidation would only take place once they have increased their market cap and the current share price.

We all know that traditionally, reverse splits do not really work to generate interest and new investment in a company. So it is not likely they are going to do this prior to conclusion of Phase 3.
Which incidently, it would be good to get an update on where things are at.

So it looks like we wait it out until at least year's end before the next meaningful rise in SP.

Stay long boys, at least the shorters and bashers have taken a bit of break too! LoL

Yellowknifer
Bullboard Posts